机构：[1]Guangzhou Center for Disease Control and Prevention, 510440 Guangzhou, Guangdong, China[2]Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, 510632 Guangzhou, Guangdong, China[3]Department of Systems Biomedical Sciences, School of Medicine, Jinan University, 510632 Guangzhou, Guangdong, China[4]GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, 511436 Guangzhou, Guangdong, China[5]BGI-Shenzhen. Beishan Industrial Zone, 11th building, Yantian District, 518055 Shenzhen, Guangdong, China[6]Department of Pathophysiology, Key Laboratory of National Administration of Traditional Chinese Medicine of the People’s Republic of China, School of Medicine, Jinan University, 510632 Guangzhou, Guangdong, China[7]Clinical Data Center, Guangdong General Hospital/Guangdong Academy of Medical Sciences, 510080 Guangzhou, Guangdong, China广东省人民医院
This work was supported by Guangdong Provincial Novel Coronavirus Scientific and
Technological Project (2020111107001 [B.D.]). National Science and Technology
Major Project of the Ministry of Science and Technology of China (2017ZX10103011
[B.D.]).
第一作者机构：[1]Guangzhou Center for Disease Control and Prevention, 510440 Guangzhou, Guangdong, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Biao Di,Hongling Jia,Oscar Junhong Luo,et al.Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics.[J].SIGNAL TRANSDUCTION AND TARGETED THERAPY.2020,5(1):doi:10.1038/s41392-020-00333-1.
APA：
Biao Di,Hongling Jia,Oscar Junhong Luo,Fangqin Lin,Kuibiao Li...&Zhicong Yang.(2020).Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics..SIGNAL TRANSDUCTION AND TARGETED THERAPY,5,(1)
MLA：
Biao Di,et al."Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics.".SIGNAL TRANSDUCTION AND TARGETED THERAPY 5..1(2020)
医学